Compare · ESTA vs ZBH
ESTA vs ZBH
Side-by-side comparison of Establishment Labs Holdings Inc. (ESTA) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ESTA and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $16.90B, about 7.7x ESTA ($2.19B).
- Over the past year, ESTA is up 94.3% and ZBH is down 5.9% - ESTA leads by 100.2 points.
- ZBH has been more active in the news (15 items in the past 4 weeks vs 11 for ESTA).
- ZBH has more recent analyst coverage (25 ratings vs 13 for ESTA).
- Company
- Establishment Labs Holdings Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $74.78+0.77%
- $87.32+0.01%
- Market cap
- $2.19B
- $16.90B
- 1M return
- +3.77%
- +4.71%
- 1Y return
- +94.31%
- -5.94%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- News (4w)
- 11
- 15
- Recent ratings
- 13
- 25
Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest ESTA
- See footnote 3 Jw Asset Management, Llc sold $6,636,886 worth of shares (90,533 units at $73.31) (SEC Form 4)
- After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
- Director Schutter Edward J was granted 2,354 shares, increasing direct ownership by 1% to 177,736 units (SEC Form 4)
- Director Slotkin Bryan was granted 2,354 shares, increasing direct ownership by 8% to 32,610 units (SEC Form 4)
- Director Custin Ann was granted 2,354 shares, increasing direct ownership by 11% to 24,086 units (SEC Form 4)
- Director Lewin Nicholas Sheridan was granted 2,354 shares, increasing direct ownership by 0.22% to 1,079,669 units (SEC Form 4)
- Director Gillin Leslie was granted 2,354 shares, increasing direct ownership by 15% to 18,398 units (SEC Form 4)
- Large owner Jw Asset Management, Llc sold $1,466,333 worth of shares (20,579 units at $71.25) (SEC Form 4)
- Establishment Labs Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
Latest ZBH
- SEC Form 4 filed by Officer Noor Jehanzeb
- Group President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)
- Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Bernard Betsy J
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Shapiro Louis
- SEC Form 4 filed by Director Kurdikar Devdatt